Did Josh Gottheimer sell Amneal Pharmaceuticals stock?

Common questions

Did Josh Gottheimer sell Amneal Pharmaceuticals stock?

Yes. Josh Gottheimer disclosed 1 sale of Amneal Pharmaceuticals (AMRX) stock on May 24, 2019, in STOCK Act reports. Added together, the disclosed ranges come to $1K-$15K.

How big were Josh Gottheimer's Amneal Pharmaceuticals trades?

STOCK Act reports give a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed ranges come to $1K-$15K.

Did Josh Gottheimer make these Amneal Pharmaceuticals trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Josh Gottheimer still own Amneal Pharmaceuticals stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Josh Gottheimer report these trades?

The latest filing is dated Jun 15, 2019. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.